![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, June 26, 2013 7:45:51 AM
By RTT News, June 26, 2013, 07:31:00 AM EDT
Vote up
(RTTNews.com) - Medivation, Inc. ( MDVN ), pursuant to its agreement with Astellas Pharma Inc.(ALPMF.PK, ALPMY.PK), Wednesday announced enrollment of the first patient in a global Phase 2 clinical trial evaluating enzalutamide as a single agent for the treatment of advanced, androgen receptor (AR)-positive, triple-negative breast cancer or TNBC. TNBC is a type of cancer which does not express any of the three most commonly targeted receptors in breast cancer; estrogen, progesterone and HER2.
Medivation added that there would be about 80 patients with AR-positive, TNBC enrolled for the trial, and each one of them will receive enzalutamide(an androgen receptor inhibitor) at a dose of 160 mg to be taken orally once daily. The primary endpoint of the trial is clinical benefit rate, defined as the proportion of patients with a best response of complete response, partial response or stable disease for 16 weeks or more than that, Medivation said.
For comments and feedback: contact editorial@rttnews.com
http://www.rttnews.com
This article appears in: News Headlines
Referenced Stocks: MDVN
Read more: http://www.nasdaq.com/article/medivation-astellas-begin-mid-stage-study-of-enzalutamide---quick-facts-20130626-00173#ixzz2XK13st4c
Recent ALPMY News
- Merck, Pfizer, Astellas Get FDA OK For Expanded Use Of Keytruda Plus Padcev • Dow Jones News • 12/15/2023 10:53:00 PM
- Astellas, Seagen: Cancer Treatment Padcev Supplemental Biologics License Application Gets FDA Priority Review • Dow Jones News • 11/30/2023 11:04:00 PM
- Merck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits Endpoints • Dow Jones News • 09/22/2023 11:02:00 AM
- Poseida Therapeutics Shares Leap on Astellas Investments • Dow Jones News • 08/07/2023 02:41:00 PM
- Poseida Therapeutics in $50 Million Investment Deal With Astellas • Dow Jones News • 08/07/2023 01:58:00 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM